BMC palliative care
-
BMC palliative care · Apr 2012
An online survey of Australian physicians reported practice with the off-label use of nebulised frusemide.
Off-label prescribing is common in palliative care. Despite inconsistent reports of the benefit of nebulised frusemide for breathlessness, its use continues to be reported. ⋯ This report adds to the series of case studies reporting some benefit from nebulised frusemide in relieving breathlessnes.